Article: The Biology and Therapeutic Potential of Nicotinamide Riboside and Nicotinamide Mononucleotide: Review

PrevNext
Cellular Health Healthy Aging & Longevity Review

The Biology and Therapeutic Potential of Nicotinamide Riboside and Nicotinamide Mononucleotide: Review

Synopsis

Research on NAD+ biology has surged, especially around two intermediates—nicotinamide riboside (NR) and nicotinamide mononucleotide (NMN)—which show promise in preventing and treating age-related conditions. While their exact metabolism and tissue-specific behavior are still being clarified, studies suggest that their effectiveness depends on where NAD-related enzymes, nucleotidases, and transporters are most active. A new framework now links NAD+ metabolism directly to aging and longevity, and the challenge ahead is to translate strong preclinical results into proven health benefits for humans.

JOURNAL

Cell Metabolism

Share

Read more

Cardiovascular Disease

Nicotinamide Riboside Protects Heart Function in Dilated Cardiomyopathy: Preclinical Findings

Synopsis In chronic heart failure, the heart’s energy metabolism is severely impaired. NAD+ is a key molecule that helps cells produce energy and respond to stress, making it an important focus in...

Read more
Muscle Health

Nicotinamide Riboside Improves Alzheimer's Features and DNA Repair: Preclinical Findings

Synopsis Alzheimer’s disease (AD) involves problems with energy metabolism and DNA repair, but how these contribute to key AD features is unclear. A DNA repair-deficient AD mouse model (3xTgAD/Pol...

Read more